最大化海洋生物材料作为细胞治疗平台潜力的策略。
Strategies to Maximize the Potential of Marine Biomaterials as a Platform for Cell Therapy.
作者信息
Kim Hyeongmin, Lee Jaehwi
机构信息
Pharmaceutical Formulation Design Laboratory, College of Pharmacy, Chung-Ang University, Seoul 156-756, Korea.
Bio-Integration Research Center for Nutra-Pharmaceutical Epigenetics, Chung-Ang University, Seoul 156-756, Korea.
出版信息
Mar Drugs. 2016 Jan 26;14(2):29. doi: 10.3390/md14020029.
Marine biopolymers have been explored as a promising cell therapy system for efficient cell delivery and tissue engineering. However, the marine biomaterial-based systems themselves have exhibited limited performance in terms of maintenance of cell viability and functions, promotion of cell proliferation and differentiation as well as cell delivery efficiency. Thus, numerous novel strategies have been devised to improve cell therapy outcomes. The strategies include optimization of physical and biochemical properties, provision of stimuli-responsive functions, and design of platforms for efficient cell delivery and tissue engineering. These approaches have demonstrated substantial improvement of therapeutic outcomes in a variety of research settings. In this review, therefore, research progress made with marine biomaterials as a platform for cell therapy is reported along with current research directions to further advance cell therapies as a tool to cure incurable diseases.
海洋生物聚合物已被探索作为一种用于高效细胞递送和组织工程的有前景的细胞治疗系统。然而,基于海洋生物材料的系统本身在维持细胞活力和功能、促进细胞增殖和分化以及细胞递送效率方面表现出有限的性能。因此,人们设计了许多新策略来改善细胞治疗效果。这些策略包括优化物理和生化特性、提供刺激响应功能以及设计用于高效细胞递送和组织工程的平台。这些方法在各种研究环境中都显示出治疗效果的显著改善。因此,在本综述中,报告了以海洋生物材料为细胞治疗平台所取得的研究进展以及当前的研究方向,以进一步推动细胞治疗作为一种治疗不治之症的工具。